Blood thinner trial aims to stop deadly clots in liver patients
NCT ID NCT07461532
Summary
This study tested if the medication Apixaban can safely prevent dangerous blood clots from forming in the main vein of the liver (portal vein) after surgery. It involved 40 people with advanced liver disease (cirrhosis) who had their spleen removed. Patients took Apixaban for a year and were monitored with ultrasound scans for up to three years to see if clots developed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Medical College
Yangzhou, Jiangsu, 225001, China
Conditions
Explore the condition pages connected to this study.